Logo image of MNST

MONSTER BEVERAGE CORP (MNST) Stock Fundamental Analysis

USA - NASDAQ:MNST - US61174X1090 - Common Stock

70.22 USD
+0.06 (+0.09%)
Last: 10/17/2025, 8:00:01 PM
70.5 USD
+0.28 (+0.4%)
After Hours: 10/17/2025, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MNST. MNST was compared to 32 industry peers in the Beverages industry. MNST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, MNST is valued expensive at the moment. With these ratings, MNST could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

In the past year MNST was profitable.
MNST had a positive operating cash flow in the past year.
In the past 5 years MNST has always been profitable.
MNST had a positive operating cash flow in each of the past 5 years.
MNST Yearly Net Income VS EBIT VS OCF VS FCFMNST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

MNST has a better Return On Assets (18.02%) than 96.88% of its industry peers.
MNST's Return On Equity of 21.88% is amongst the best of the industry. MNST outperforms 81.25% of its industry peers.
The Return On Invested Capital of MNST (22.67%) is better than 96.88% of its industry peers.
MNST had an Average Return On Invested Capital over the past 3 years of 19.65%. This is significantly above the industry average of 10.90%.
The 3 year average ROIC (19.65%) for MNST is below the current ROIC(22.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 18.02%
ROE 21.88%
ROIC 22.67%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
MNST Yearly ROA, ROE, ROICMNST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With an excellent Profit Margin value of 20.54%, MNST belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
MNST's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 28.59%, MNST belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
MNST's Operating Margin has declined in the last couple of years.
MNST has a better Gross Margin (55.18%) than 71.88% of its industry peers.
MNST's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 28.59%
PM (TTM) 20.54%
GM 55.18%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
MNST Yearly Profit, Operating, Gross MarginsMNST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MNST has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MNST has less shares outstanding
MNST has less shares outstanding than it did 5 years ago.
MNST has a worse debt/assets ratio than last year.
MNST Yearly Shares OutstandingMNST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MNST Yearly Total Debt VS Total AssetsMNST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 30.20 indicates that MNST is not in any danger for bankruptcy at the moment.
MNST has a better Altman-Z score (30.20) than 100.00% of its industry peers.
There is no outstanding debt for MNST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 30.2
ROIC/WACC2.62
WACC8.66%
MNST Yearly LT Debt VS Equity VS FCFMNST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

MNST has a Current Ratio of 3.52. This indicates that MNST is financially healthy and has no problem in meeting its short term obligations.
MNST has a better Current ratio (3.52) than 93.75% of its industry peers.
A Quick Ratio of 3.00 indicates that MNST has no problem at all paying its short term obligations.
The Quick ratio of MNST (3.00) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.52
Quick Ratio 3
MNST Yearly Current Assets VS Current LiabilitesMNST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.64% over the past year.
MNST shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.72% yearly.
Looking at the last year, MNST shows a small growth in Revenue. The Revenue has grown by 3.70% in the last year.
MNST shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.27% yearly.
EPS 1Y (TTM)8.64%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%24.39%
Revenue 1Y (TTM)3.7%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%11.1%

3.2 Future

The Earnings Per Share is expected to grow by 14.75% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.32% on average over the next years. This is quite good.
EPS Next Y20.83%
EPS Next 2Y16.45%
EPS Next 3Y13.96%
EPS Next 5Y14.75%
Revenue Next Year7.8%
Revenue Next 2Y8.11%
Revenue Next 3Y7.69%
Revenue Next 5Y8.32%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNST Yearly Revenue VS EstimatesMNST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
MNST Yearly EPS VS EstimatesMNST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 39.90, the valuation of MNST can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as MNST.
MNST is valuated rather expensively when we compare the Price/Earnings ratio to 27.40, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 32.16, the valuation of MNST can be described as expensive.
MNST's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of MNST to the average of the S&P500 Index (22.94), we can say MNST is valued slightly more expensively.
Industry RankSector Rank
PE 39.9
Fwd PE 32.16
MNST Price Earnings VS Forward Price EarningsMNST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

62.50% of the companies in the same industry are cheaper than MNST, based on the Enterprise Value to EBITDA ratio.
MNST's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 36.96
EV/EBITDA 29.04
MNST Per share dataMNST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of MNST may justify a higher PE ratio.
MNST's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.92
PEG (5Y)N/A
EPS Next 2Y16.45%
EPS Next 3Y13.96%

More info and screens

0

5. Dividend

5.1 Amount

MNST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONSTER BEVERAGE CORP

NASDAQ:MNST (10/17/2025, 8:00:01 PM)

After market: 70.5 +0.28 (+0.4%)

70.22

+0.06 (+0.09%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)10-30 2025-10-30/amc
Inst Owners68.78%
Inst Owner Change0.11%
Ins Owners0.49%
Ins Owner Change-0.36%
Market Cap68.56B
Analysts76
Price Target67.84 (-3.39%)
Short Float %2.77%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.94%
Min EPS beat(2)-0.21%
Max EPS beat(2)4.08%
EPS beat(4)1
Avg EPS beat(4)-2.85%
Min EPS beat(4)-8.27%
Max EPS beat(4)4.08%
EPS beat(8)2
Avg EPS beat(8)-3.63%
EPS beat(12)3
Avg EPS beat(12)-2.74%
EPS beat(16)3
Avg EPS beat(16)-5.18%
Revenue beat(2)0
Avg Revenue beat(2)-4.34%
Min Revenue beat(2)-8.24%
Max Revenue beat(2)-0.44%
Revenue beat(4)0
Avg Revenue beat(4)-3.28%
Min Revenue beat(4)-8.24%
Max Revenue beat(4)-0.44%
Revenue beat(8)0
Avg Revenue beat(8)-3.56%
Revenue beat(12)0
Avg Revenue beat(12)-3.65%
Revenue beat(16)3
Avg Revenue beat(16)-2.15%
PT rev (1m)0.14%
PT rev (3m)6.79%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)4.29%
EPS NY rev (1m)0.08%
EPS NY rev (3m)2.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE 39.9
Fwd PE 32.16
P/S 8.95
P/FCF 36.96
P/OCF 33.39
P/B 9.53
P/tB 15.44
EV/EBITDA 29.04
EPS(TTM)1.76
EY2.51%
EPS(NY)2.18
Fwd EY3.11%
FCF(TTM)1.9
FCFY2.71%
OCF(TTM)2.1
OCFY3%
SpS7.84
BVpS7.36
TBVpS4.55
PEG (NY)1.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.02%
ROE 21.88%
ROCE 29.31%
ROIC 22.67%
ROICexc 31.37%
ROICexgc 63.95%
OM 28.59%
PM (TTM) 20.54%
GM 55.18%
FCFM 24.22%
ROA(3y)16.92%
ROA(5y)18.23%
ROE(3y)20.7%
ROE(5y)22.08%
ROIC(3y)19.65%
ROIC(5y)20.53%
ROICexc(3y)29.02%
ROICexc(5y)32.32%
ROICexgc(3y)64.44%
ROICexgc(5y)84.58%
ROCE(3y)25.4%
ROCE(5y)26.54%
ROICexcg growth 3Y-12.83%
ROICexcg growth 5Y-13.62%
ROICexc growth 3Y-5.49%
ROICexc growth 5Y-2.02%
OM growth 3Y-5.5%
OM growth 5Y-3.99%
PM growth 3Y-6.78%
PM growth 5Y-5.25%
GM growth 3Y-1.24%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 213.85%
Cap/Sales 2.59%
Interest Coverage 75.62
Cash Conversion 89.98%
Profit Quality 117.9%
Current Ratio 3.52
Quick Ratio 3
Altman-Z 30.2
F-Score7
WACC8.66%
ROIC/WACC2.62
Cap/Depr(3y)319.34%
Cap/Depr(5y)225.06%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.29%
Profit Quality(3y)86.9%
Profit Quality(5y)86.95%
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y-10.82%
EPS 5Y-4.72%
EPS Q2Q%24.39%
EPS Next Y20.83%
EPS Next 2Y16.45%
EPS Next 3Y13.96%
EPS Next 5Y14.75%
Revenue 1Y (TTM)3.7%
Revenue growth 3Y10.58%
Revenue growth 5Y12.27%
Sales Q2Q%11.1%
Revenue Next Year7.8%
Revenue Next 2Y8.11%
Revenue Next 3Y7.69%
Revenue Next 5Y8.32%
EBIT growth 1Y8.74%
EBIT growth 3Y4.5%
EBIT growth 5Y7.79%
EBIT Next Year19.03%
EBIT Next 3Y11.94%
EBIT Next 5Y11.93%
FCF growth 1Y37.56%
FCF growth 3Y14.4%
FCF growth 5Y10.46%
OCF growth 1Y35.1%
OCF growth 3Y18.61%
OCF growth 5Y11.61%